Jennifer Spratlin

BOLD-100 in Combination with FOLFOX Is a Broadly Effective Therapeutic Strategy for Gastric Cancer

Gastric cancer has limited therapeutic options for advanced-stage disease and remains a major contributor to global cancer mortality. BOLD-100, a ruthenium-based compound that inhibits glucose-regulated protein (GRP78), has shown potential to enhance chemotherapy efficacy by disr...